Cardiovascular safety and benefits of GLP-1 receptor agonists
Year: 2017
Type: article
Source: Expert Opinion on Drug Safety
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk Fonden
Awards: G1551214306, G2790715585, G4899559972
OpenAlex ID: W2571824959
